Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of phenylimidazoles and azoles. It has been assigned DrugBank ID DB07125 and is also known by the code names PD006082 and 4RB. The molecule features an imidazo[1,2-b]pyridazine core substituted with a benzoic acid moiety. There are no approved medical indications or clinical trials reported for this compound as of now. Its mechanism of action and biological targets have not been described in public databases or literature sources available as of June 2025. The compound appears to be experimental with no evidence of development for any specific disease or therapeutic area.[1][9][5]
- Other names
- 4-(6-{[(2R)-1-hydroxybutan-2-yl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acidBenzoic acid, 4-[6-[[(1R)-1-(hydroxymethyl)propyl]amino]imidazo[1,2-b]pyridazin-3-yl]
02
Targets
DAPK3 (Death-associated protein kinase 3)
Beyond the preview
Go deeper on 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid.